# Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

> **NCT00022087** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 439 (actual)

## Conditions studied

- Breast Cancer
- Osteoporosis

## Interventions

- **DIETARY_SUPPLEMENT:** calcium salts
- **DIETARY_SUPPLEMENT:** cholecalciferol
- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00022087
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2007-03
- **Final completion:** 2009-02
- **Target enrollment:** 439 (ACTUAL)
- **Last updated:** 2016-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00022087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00022087, "Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00022087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*